Skip to content

Shield Bio

YC S16 · Inactive · Bringing 3rd generation, nanopore sequencing to healthcare to solve…

Competitors

Adjacent

Also from S16

All of S16

About Shield Bio

Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.

YC batch
S16 · Summer 2016
Status, per YC
Inactive
Category
Other
Team size
28
Location
San Francisco, CA, USA; San Jose, CA, USA
Checked
1h ago

YC tags: Healthcare, Genomics, Nanotechnology

Shield Bio in S16: 102 companies, 18% AI

Shield Bio: questions

Which YC batch was Shield Bio in?

Shield Bio was in Y Combinator's Summer 2016 batch (S16).

Is Shield Bio still active?

Y Combinator lists Shield Bio as inactive.

Where is Shield Bio based?

Shield Bio lists San Francisco, CA, USA; San Jose, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.